SCHEMBL24252697

SCHEMBL24252697

c1cncc(-c2ccc(-c3cc(-c4ccc(-c5cccnc5)cc4)nc(-c4cccc(-c5cc6ccccc6c6ccccc56)c4)n3)cc2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 8/20 0.65
DHODH Q02127 1/20 0.48
CYP11B2 P19099 7/20 0.46
CYP19A1 P11511 2/20 0.46
CYP17A1 P05093 1/20 0.46
GPR84 Q9NQS5 1/20 0.43
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
CYP2A6 P11509 3/20 0.40
HIPK2 Q9H2X6 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17808075 0.99 CYP11B1 (0.63) CYP11B1DHODHCYP11B2CYP19A1CYP17A1
SCHEMBL17917999 0.96 CYP11B1 (0.60) CYP11B1DHODHCYP11B2CYP19A1CYP17A1
SCHEMBL17013959 0.95 CYP11B1 (0.59) CYP11B1DHODHCYP11B2CYP19A1CYP17A1
SCHEMBL17918144 0.95 CYP11B1 (0.62) CYP11B1DHODHCYP11B2CYP19A1CYP17A1
SCHEMBL17808077 0.95 CYP11B1 (0.62) CYP11B1DHODHCYP11B2CYP19A1CYP17A1
SCHEMBL17918039 0.95 CYP11B1 (0.62) CYP11B1DHODHCYP11B2CYP19A1CYP17A1
SCHEMBL30296744 0.95 CYP11B1 (0.62) CYP11B1DHODHCYP11B2CYP19A1CYP17A1
SCHEMBL17808073 0.94 CYP11B1 (0.58) CYP11B1DHODHCYP11B2CYP19A1CYP17A1
SCHEMBL21725414 0.94 CYP11B1 (0.58) CYP11B1DHODHCYP11B2CYP19A1CYP17A1
SCHEMBL17808149 0.94 CYP11B1 (0.58) CYP11B1DHODHCYP11B2CYP19A1CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220052268-A1 COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220052268-A1 COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT SLC29A1, NUDT1, SLC29A2 CYP11B1 4052/4885DHODH 202/4885CYP11B2 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.